Advances in external beam radiotherapy for treatment of localized prostate cancer

In the past year or so there have been three significant technological advances in the use of external beam radiotherapy for the treatment of localized prostate cancer, and we want to be sure that the patient community is both aware of and understands the limitations of these technological advances.

The regional vagaries of Medicare coverage (in the USA)

An article in today’s New York Times addresses an issue of potentially growing importance for Medicare beneficiaries with prostate cancer. Is the form of treatment you want covered where you live?

Cyberknives, efficacy, safety, and money

An article in the Washington Post, published last Friday, offers some interesting insights into the current glut of information about the potential for Cyberknife radiation therapy in the treatment of prostate cancer. This is an issue on which we first commented back in July.

CyberKnife “robotic radiosurgery” for localized prostate cancer …

… Are we getting things out of proportion? The CyberKnife® system  was initially developed as a method to treat tumors in places like the brain that were inaccessible to physical surgery, and was originally approved by the FDA in 1992. Now it is being touted as “the next thing” in “radiosurgery” for prostate cancer.

Follow

Get every new post delivered to your Inbox.

Join 332 other followers